{{cart_num}}
My Cart> Peptides > Substrate and Enzyme Inhibitors > Fibrinogen Binding Inhibitor PeptideCAS：89105-94-2
Purity：≥95%
Appearance：Lyophilized powder
Storage：Store at -20℃，2 years.(Avoid freeze/thaw cycles)
Qty：
Size：
| Product Type | Peptides |
| CAS | 89105-94-2 |
| Sequence(1LC) | HHLGGAKQAGDV |
| Sequence(3LC) | His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val |
| Molecular Formula | C50H80N18O16 |
| Molecular Weight | 1189.3 |
| Purity | ≥95% |
| Appearance | Lyophilized powder |
| Solubility | DMSO：100 mg/mL; H2O：100 mg/mL; *Ultrasonic solubilization; |
| Salt Form | Trifluoroacetate salt |
| Source | Synthetic |
| Storage | Store at -20℃，2 years.(Avoid freeze/thaw cycles) |
| Category/Label | Substrate and Enzyme Inhibitors |
| Background | The synthetic dodecapeptide HHLGGAKQAGDV represents the specific platelet receptor recognition site of the human fibrinogen γ chain (residues 400-411). It is a potent inhibitor of the binding of fibrinogen, fibronectin, and von Willebrand factor to thrombin-or ADP-stimulated platelets. The peptide has also been used in studying phosphorylation processes associated with platelet activation. |
| In Vitro | undetected |
| Reference | [1] Farrell, DH. et al. Proc. Natl. Acad. Sci. 89:10729-10732 (1992). |
| Unit | Bottle |
| Specification | 1mg 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
